Our approach to R&D is rooted in a deep understanding of the underlying mechanisms of disease. We apply our expertise across multiple treatment modalities to address a broad range of serious medical conditions.
Our industry-leading R&D program has a track record of successfully ushering in new medicines built from the foundations of genetic insights. We bring together leading experts across disciplines, combining a wide range of subject matter expertise and technical skills, as well as diversity of experience. We then empower those teams to work collaboratively in pursuit of breakthrough science.
We got our start developing enzyme replacement therapies for ultra-rare genetic conditions. In the two decades since, we’ve significantly expanded our areas of expertise – while always remaining firmly grounded in leveraging genetic insights and mechanistic understanding to develop transformative medicines. Today, our treatment modalities include:
See how we’re applying our technical expertise across these areas of focus with our approved medicines and pipeline.
